Fever & Acute Responses — Fever and acute responses (overview) - Microbiology

SECTION 1

Historical Context & Motivation

Throughout most of medical history, fever was regarded not as a symptom of disease but as the disease itself. Ancient physicians from Hippocrates to Galen described fever as an imbalance of the four humors — an excess of yellow bile generating heat within the body. This humoral framework dominated Western medicine for nearly two millennia, and therapeutic interventions centered on bloodletting and purgation to restore equilibrium. It was not until the rise of experimental physiology in the nineteenth century that investigators began to suspect fever was an active, regulated physiological process rather than a passive consequence of pathology. Understanding this shift is essential to appreciating how modern immunology conceptualizes the acute-phase response as a coordinated, host-protective program.

1868 • Wunderlich Establishes Normal Body Temperature

Carl Reinhold August Wunderlich published data from over one million axillary temperature readings, establishing 37 °C (98.6 °F) as the average normal human body temperature and demonstrating that fever follows characteristic temporal patterns in different diseases.

1943 • Menkin Identifies Pyrexin

Valy Menkin isolated a heat-stable protein fraction from inflammatory exudates that could induce fever when injected into animals, providing early evidence that endogenous molecules — not just exogenous toxins — mediate pyrogenesis.

1953 • Beeson Demonstrates Endogenous Pyrogen

Paul B. Beeson showed that leukocytes activated by bacterial endotoxin release an endogenous pyrogen capable of resetting the hypothalamic thermostat, establishing the concept of cytokine-mediated fever.

1977 • Dinarello Purifies Interleukin-1

Charles Dinarello purified the human endogenous pyrogen and later identified it as interleukin-1 (IL-1), linking fever to the nascent field of cytokine biology and opening the door to molecular characterization of the acute-phase response.

1990s • Acute-Phase Proteins and Systemic Integration

Large-scale clinical studies established C-reactive protein (CRP) and serum amyloid A as reliable biomarkers of the acute-phase response, integrating fever, hepatic protein synthesis, and leukocyte trafficking into a unified model of innate immunity.

The central question that drove this century of research remains the organizing principle of this lesson: How does the host mount a rapid, systemic defense in the first hours to days after encountering a pathogen, and what molecular circuitry connects microbial recognition to elevated body temperature, altered plasma protein composition, and recruitment of inflammatory cells? These phenomena — collectively termed the fever and acute-phase response — represent one of the oldest and most conserved arms of innate immunity.

SECTION 2

Core Principles & Definitions

The acute-phase response is a complex, multi-organ reaction initiated within hours of tissue injury or infection. Rather than a single pathway, it involves a cascade of events that begins with local recognition of pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs) by sentinel immune cells, progresses through cytokine signaling, and culminates in systemic physiological changes including fever, hepatic acute-phase protein synthesis, leukocytosis, and behavioral modifications such as anorexia and somnolence. Four foundational principles anchor the biology of this response.

Pyrogenesis

Fever results from a regulated upward resetting of the hypothalamic thermoregulatory set-point, driven primarily by prostaglandin E₂ (PGE₂) acting on neurons in the preoptic area of the anterior hypothalamus. This distinguishes fever from hyperthermia, which involves unregulated heat gain.

Endogenous Pyrogens

Pro-inflammatory cytokines — chiefly IL-1β, IL-6, and TNF-α — serve as endogenous pyrogens. Released by activated macrophages, dendritic cells, and other sentinel cells, these cytokines circulate to the hypothalamus and induce cyclooxygenase-2 (COX-2) dependent PGE₂ synthesis.

Acute-Phase Proteins

IL-6 is the principal driver of hepatic acute-phase protein (APP) synthesis. Positive APPs — CRP, serum amyloid A, fibrinogen, hepcidin, and complement components — increase dramatically, while negative APPs — albumin and transferrin — decrease, reflecting a reallocation of hepatic synthetic capacity.

Systemic Mobilization

The acute response induces leukocytosis (increased circulating white blood cells), activates the complement cascade, enhances phagocyte microbicidal activity at febrile temperatures, and triggers sickness behavior mediated by cytokine action on the central nervous system.

✦

KEY TAKEAWAY

Think of the acute-phase response as a building's fire alarm system: the initial sensor (macrophage pattern-recognition receptor) detects smoke (PAMPs), triggers a centralized alarm (cytokines reaching the hypothalamus), and activates building-wide responses — sprinklers engage (fever raises set-point), security doors lock (iron sequestration via hepcidin), fire trucks are dispatched (neutrophil mobilization), and the PA system broadcasts instructions (sickness behavior alters host activity). The response is coordinated, systemic, and temporally organized, not a random collection of symptoms.

SECTION 3

Visual Explanation — The Fever Pathway

The diagram traces the fever pathway from exogenous pyrogen (pathogen PAMPs) through macrophage activation and release of endogenous pyrogens (IL-1β, TNF-α, IL-6), to the hypothalamic set-point elevation via PGE₂. Parallel pathways to the liver, bone marrow, and CNS illustrate the systemic scope of the acute-phase response. The dashed box at right shows the pharmacological intervention point where NSAIDs block COX-2 to reduce PGE₂ production.

The pathway depicted above illustrates a critical distinction between exogenous pyrogens and endogenous pyrogens. Exogenous pyrogens are microbial products — lipopolysaccharide (LPS) from Gram-negative bacteria being the prototypical example — that are recognized by pattern-recognition receptors (PRRs) such as Toll-like receptor 4 (TLR4). Upon engagement, intracellular signaling cascades activate NF-κB, leading to transcription and secretion of the classic pyrogenic cytokines. These endogenous pyrogens then reach the organum vasculosum of the lamina terminalis (OVLT), a circumventricular organ lacking a complete blood–brain barrier, where they stimulate perivascular cells to produce PGE₂ via the COX-2 enzyme. PGE₂ binds EP3 receptors on thermoregulatory neurons in the preoptic area, raising the thermostat's set-point and triggering effector mechanisms — peripheral vasoconstriction conserves heat, shivering generates heat, and the patient experiences chills until core temperature reaches the new set-point.

SECTION 4

Molecular Mechanisms of the Acute-Phase Response

While fever is the most clinically obvious manifestation of the acute-phase response, the underlying molecular machinery orchestrates changes across multiple organ systems simultaneously. This section examines the signaling cascades and effector mechanisms in greater depth, emphasizing the role of cytokine networks and the hepatic acute-phase protein program.

Cytokine Signaling Cascades

The three principal pyrogenic cytokines — IL-1β, TNF-α, and IL-6 — have overlapping but distinct roles. IL-1β and TNF-α are early-response cytokines produced rapidly by macrophages upon TLR engagement; they act in an autocrine/paracrine fashion to amplify local inflammation and also reach the systemic circulation. IL-6 production is stimulated in part by IL-1β itself, creating a feed-forward loop. Importantly, IL-6 is the dominant inducer of the hepatic acute-phase response, acting through the JAK-STAT3 signaling pathway in hepatocytes. This cascade drives the transcription of positive acute-phase proteins — those whose serum concentrations rise — while simultaneously suppressing negative acute-phase proteins such as albumin and transferrin. The net result is a reprogramming of hepatic protein output toward immune defense.

PGE₂ Synthesis — The Final Common Pathway

PROSTAGLANDIN E₂ SYNTHESIS

Arachidonic Acid → (COX-2) → PGH₂ → (mPGES-1) → PGE₂

Arachidonic acid is released from membrane phospholipids by phospholipase A₂. COX-2 (cyclooxygenase-2) converts it to PGH₂, which is then isomerized to PGE₂ by microsomal PGE synthase-1 (mPGES-1). COX-2 is the inducible isoform upregulated by NF-κB signaling, making it the pharmacological target of NSAIDs.

Thermoregulatory Set-Point Elevation

The preoptic area of the anterior hypothalamus functions as the body's thermostat. Under normal conditions, warm-sensitive neurons fire at rates proportional to core temperature, driving heat-dissipation responses when temperature exceeds the set-point (≈37 °C). PGE₂ binding to EP3 receptors inhibits the firing of these warm-sensitive neurons, effectively raising the set-point. The hypothalamus now interprets normal body temperature as 'too cold,' triggering heat conservation (cutaneous vasoconstriction) and heat generation (shivering thermogenesis, increased metabolic rate). Body temperature climbs until it matches the new elevated set-point, typically in the range of 38–41 °C. When the pyrogen stimulus subsides — for example, as infection is controlled — PGE₂ levels fall, the set-point returns to normal, and heat-dissipation mechanisms (vasodilation, sweating) activate, producing defervescence.

CRP CONCENTRATION KINETICS

CRP(t) ≈ CRP₀ × e^(k × t) during the rising phase

Where CRP₀ is the baseline serum concentration (typically <5 mg/L), k is the rate constant determined by IL-6 stimulation intensity, and t is time after onset. CRP can increase up to 1000-fold within 24–48 hours, making it one of the most dynamic biomarkers in clinical medicine. The exponential model is an approximation valid during the initial rising phase before hepatic synthesis reaches saturation.

SECTION 5

Acute-Phase Proteins — Classification and Functions

The hepatic response to inflammatory cytokines produces a dramatic shift in the plasma protein profile. Acute-phase proteins (APPs) are defined as plasma proteins whose concentration changes by at least 25% during inflammation. Positive APPs increase and contribute to host defense through opsonization, complement activation, coagulation, and metal ion sequestration. Negative APPs decrease, reflecting the liver's reallocation of amino acids and synthetic machinery toward defensive protein production. The following diagram and table detail the major players and their immunological roles.

This diagram shows the hepatocyte's response to IL-6 stimulation via the JAK-STAT3 pathway. Positive APPs (green, cyan, amber, pink boxes) increase in concentration, while negative APPs (orange boxes) decrease. The net effect is a reallocation of hepatic synthetic capacity from housekeeping functions to immune defense.

Protein	Type	Fold Change	Primary Function
C-reactive protein	Positive	↑ 100–1000×	Opsonization; classical complement activation via C1q binding
Serum amyloid A	Positive	↑ 100–1000×	Cholesterol transport; monocyte chemotaxis; may contribute to amyloidosis if chronic
Fibrinogen	Positive	↑ 2–5×	Coagulation; wound containment; drives elevated ESR
Hepcidin	Positive	↑ 5–20×	Blocks ferroportin → sequesters iron from pathogens
Mannose-binding lectin	Positive	↑ 2–3×	Lectin pathway complement activation; opsonization
Albumin	Negative	↓ 0.5–0.8×	Amino acids reallocated to positive APP synthesis
Transferrin	Negative	↓ 0.5–0.7×	Decreased iron transport compounds hepcidin-mediated sequestration

Major acute-phase proteins: classification, magnitude of change, and immunological function

SECTION 6

Worked Example — Interpreting an Acute-Phase Response

Consider the following clinical scenario: A 22-year-old college student presents to the university health center with a 2-day history of sore throat, fever (39.2 °C), malaise, and myalgia. A rapid strep test is positive for Group A Streptococcus pyogenes. Blood work reveals a white blood cell count of 14,500/μL (reference: 4,500–11,000/μL), CRP of 85 mg/L (reference: <5 mg/L), and serum albumin of 3.1 g/dL (reference: 3.5–5.5 g/dL). Let us trace the immunological logic of these findings step by step.

Tracing the Acute-Phase Response in Streptococcal Pharyngitis

1
Step 1 — Identify the Exogenous Pyrogen

Group A S. pyogenes possesses multiple PAMPs, including lipoteichoic acid and peptidoglycan — components of its Gram-positive cell wall. These are recognized by TLR2 and TLR6 on pharyngeal macrophages and dendritic cells, initiating NF-κB signaling.

Exogenous pyrogens: lipoteichoic acid and peptidoglycan recognized by TLR2/6
2
Step 2 — Endogenous Pyrogen Release

TLR engagement activates tissue macrophages, which secrete IL-1β, TNF-α, and IL-6. These cytokines enter the bloodstream and reach the hypothalamus (OVLT). They also act locally to upregulate endothelial adhesion molecules (E-selectin, ICAM-1), promoting neutrophil recruitment to the pharyngeal tissue.

Endogenous pyrogens IL-1β, TNF-α, IL-6 released; local and systemic effects initiated
3
Step 3 — Fever Generation

At the OVLT, IL-1β and IL-6 induce COX-2 expression in perivascular cells. COX-2 converts arachidonic acid to PGH₂, then to PGE₂ via mPGES-1. PGE₂ binds EP3 receptors on preoptic neurons, raising the thermoregulatory set-point. The patient's core temperature rises from 37 °C to 39.2 °C — a 2.2 °C elevation achieved through vasoconstriction and shivering.

Set-point elevated to 39.2 °C via PGE₂ → EP3 receptor axis
4
Step 4 — Interpret the Laboratory Findings

The WBC count of 14,500/μL reflects leukocytosis — predominantly a neutrophilia driven by IL-1β and G-CSF stimulating bone marrow release and demargination of neutrophils from the vascular endothelium. CRP at 85 mg/L (a 17-fold increase) reflects robust IL-6–driven hepatic synthesis. CRP will opsonize the bacteria by binding phosphocholine in the streptococcal membrane and will activate complement via C1q. Albumin at 3.1 g/dL (decreased) reflects the hepatic shift from constitutive protein synthesis toward acute-phase protein production — a hallmark negative acute-phase response.

Leukocytosis, elevated CRP, decreased albumin = classic acute-phase response triad
5
Step 5 — Predict Defervescence

Upon initiation of antibiotic therapy (penicillin), bacterial load decreases, reducing PAMP stimulation of macrophages. Cytokine production falls, PGE₂ levels decline, and the hypothalamic set-point returns to 37 °C. The patient now perceives their febrile temperature as 'too hot' and activates heat-dissipation mechanisms — vasodilation and sweating — leading to defervescence. CRP, with a half-life of ≈19 hours, will begin to fall within 24–48 hours of effective therapy and can serve as a marker of treatment response.

Defervescence occurs as PGE₂ declines; CRP half-life ≈ 19 hours tracks recovery

SECTION 7

Fever — Adaptive Benefits vs. Pathological Risks

Fever is among the most evolutionarily conserved host responses, present in vertebrates and even some invertebrates and plants. This deep conservation suggests strong selective pressure favoring febrile organisms — yet fever also carries metabolic costs and, at extreme temperatures, tissue damage. Understanding this trade-off is clinically relevant because it informs decisions about whether and when to administer antipyretic therapy.

Adaptive Benefits of Fever	Pathological Risks of Fever
Enhanced neutrophil and macrophage migration, phagocytosis, and oxidative burst at 39–40 °C	Each 1 °C rise increases metabolic rate by ≈10–13%, imposing caloric demand that may be unsustainable in malnourished or critically ill patients
Increased T-cell proliferation and cytokine production at febrile temperatures	Temperatures >41.5 °C (hyperpyrexia) may denature enzymes and damage the CNS — risk of febrile seizures in young children
Impaired growth of some temperature-sensitive pathogens (e.g., Treponema pallidum, Neisseria gonorrhoeae)	Increased cardiac output and oxygen consumption can precipitate cardiac ischemia in patients with pre-existing coronary artery disease
Iron sequestration (via hepcidin) deprives bacteria of a critical nutrient	Prolonged fever in chronic infections (e.g., tuberculosis) contributes to cachexia and muscle wasting
Upregulation of heat-shock proteins (HSPs) enhances antigen presentation and cytoprotection	In sepsis, uncontrolled cytokine production can lead to systemic inflammatory response syndrome (SIRS) and multi-organ failure

Adaptive benefits versus pathological risks of the febrile response

⚕

CLINICAL PERSPECTIVE

The decision to use antipyretics can be likened to a cost–benefit analysis in engineering: you are deciding whether to let a controlled burn (fever) eliminate a threat or to suppress it before collateral damage exceeds the benefit. Current evidence suggests that moderate fever (38–40 °C) is generally immunologically beneficial and routine antipyretic therapy in otherwise healthy patients may prolong some infections. However, in patients with cardiovascular compromise, neurological vulnerability, or extreme hyperpyrexia (>41 °C), the risks of uncontrolled fever clearly outweigh its benefits.

SECTION 8

Connection to Advanced Immunology — From Innate to Adaptive

The fever and acute-phase response, while classified under innate immunity, profoundly influences the subsequent adaptive immune response. This bridging function positions the acute-phase response as a critical node in the larger network of host defense. Several advanced topics build directly upon the principles covered in this overview.

Concept Covered Here	Advanced Extension	Connection
IL-1β, TNF-α, IL-6 as pyrogens	Inflammasome biology	IL-1β is produced as an inactive precursor (pro–IL-1β) and requires caspase-1 cleavage by the NLRP3 inflammasome for secretion — a key topic in autoinflammatory disease
CRP and complement activation	Complement cascades	CRP activates the classical pathway via C1q. The lectin pathway is triggered by MBL. Understanding all three complement initiation pathways is essential for advanced immunology
Leukocytosis and neutrophil recruitment	Selectin–integrin adhesion cascade	The molecular details of neutrophil rolling (selectins), firm adhesion (integrins/ICAM-1), and diapedesis are critical to understanding tissue inflammation
Cytokines bridging innate and adaptive	T-helper cell differentiation	IL-6, in combination with TGF-β, drives Th17 differentiation; IL-1β and IL-6 together influence the balance between Treg and Th17 populations
Fever vs. hyperthermia distinction	Sepsis and SIRS	Dysregulated acute-phase responses underlie the pathophysiology of septic shock; understanding normal fever provides the baseline for recognizing pathological deviation

Connections from the acute-phase response to advanced immunological topics

As you progress through microbiology and immunology coursework, you will encounter these advanced topics as natural extensions of the fever and acute-phase framework. The cytokine network introduced here — IL-1β, TNF-α, and IL-6 — reappears throughout adaptive immunity, autoimmune disease, and even cancer immunology. Mastery of the signaling logic in this lesson (PAMP → PRR → NF-κB → cytokines → hypothalamic PGE₂ → fever; IL-6 → JAK-STAT3 → APPs) will serve as a conceptual scaffold onto which more complex material can be built.

SECTION 9

Practice Problems

Question 1: CONCEPTUAL

Explain the mechanistic difference between fever and hyperthermia. Why is this distinction clinically important, and how would you expect each condition to respond to administration of an NSAID such as ibuprofen?

Show answer

Fever is a regulated elevation of the hypothalamic thermoregulatory set-point mediated by PGE₂ acting on EP3 receptors in the preoptic area; the body actively generates and conserves heat to reach this new, elevated set-point. Hyperthermia, by contrast, results from unregulated heat gain — as in heat stroke or malignant hyperthermia — where the set-point remains at 37 °C but heat-dissipation mechanisms are overwhelmed. NSAIDs such as ibuprofen inhibit COX-2, reducing PGE₂ synthesis and lowering the set-point back toward normal, making them effective against fever. In hyperthermia, however, PGE₂ is not the proximate cause; therefore, NSAIDs will be ineffective, and treatment relies on physical cooling measures. This distinction guides clinical management: antipyretics treat fever but not hyperthermia.

Question 2: BASIC CALCULATION

A patient's baseline CRP is 3 mg/L. During an acute bacterial infection, IL-6 stimulation causes CRP to increase approximately 200-fold. What is the expected peak CRP concentration? If CRP has a plasma half-life of approximately 19 hours, estimate how long after effective antibiotic initiation it will take for CRP to fall back below 10 mg/L, assuming production ceases immediately upon treatment.

Show answer

Peak CRP = 3 mg/L × 200 = 600 mg/L. Once production ceases, CRP decays with a half-life of ≈19 hours. Using exponential decay: CRP(t) = 600 ×

(0.5)^{t/19}

. We need CRP(t) < 10 mg/L. Solving: 10 = 600 ×

(0.5)^{t/19}

→

(0.5)^{t/19}

= 10/600 = 0.0167 → t/19 = log(0.0167)/log(0.5) = (−1.778)/(−0.301) ≈ 5.91 → t ≈ 5.91 × 19 ≈ 112 hours ≈ 4.7 days. So CRP would fall below 10 mg/L roughly 4–5 days after effective therapy eliminates the cytokine stimulus. In practice, this timeline is modestly longer because hepatic production does not cease instantaneously.

Question 3: INTERMEDIATE

A researcher creates a knockout mouse lacking the gene encoding the EP3 prostaglandin receptor. Predict the phenotype of this mouse when challenged with intraperitoneal injection of bacterial LPS. Specifically address: (a) fever response, (b) circulating cytokine levels, (c) hepatic acute-phase protein levels, and (d) leukocyte count.

Show answer

(a) The EP3 receptor knockout mouse would fail to develop fever upon LPS challenge, because PGE₂ cannot signal to preoptic warm-sensitive neurons to raise the thermoregulatory set-point — this is the final common pathway for pyrogenesis. (b) Circulating IL-1β, TNF-α, and IL-6 levels should be largely unaffected or only modestly altered, because these cytokines are produced upstream of the EP3 receptor; TLR4 recognition of LPS and NF-κB–driven cytokine transcription remain intact. (c) Hepatic acute-phase proteins, particularly CRP, should still be elevated because their induction depends on IL-6 signaling through the JAK-STAT3 pathway in hepatocytes — a pathway independent of EP3. (d) Leukocytosis should still occur, driven by G-CSF, IL-1β, and other factors that stimulate bone marrow neutrophil release. In summary, the EP3 knockout selectively abolishes fever while leaving other components of the acute-phase response intact, demonstrating that fever is dissociable from the broader inflammatory program.

Question 4: APPLIED

A hospitalized patient with bacterial pneumonia has the following serial CRP values: Day 1: 150 mg/L; Day 3: 220 mg/L; Day 5: 180 mg/L; Day 7: 40 mg/L. The patient was started on antibiotics on Day 2. Interpret this CRP trajectory in the context of the acute-phase response, and explain why CRP continued to rise between Days 1 and 3 despite antibiotic therapy.

Show answer

The CRP trajectory reflects the kinetics of the acute-phase response and antibiotic pharmacodynamics. On Day 1 (pre-antibiotic), active infection drives IL-6 production, stimulating hepatic CRP synthesis. Antibiotics were initiated on Day 2, but bacterial killing and the consequent reduction in PAMP-driven cytokine stimulation are not instantaneous — there is a lag period during which bacterial load decreases and, paradoxically, lysis may transiently release additional PAMPs. Furthermore, CRP mRNA has already been transcribed and CRP protein already in the secretory pathway; hepatic production continues until IL-6 levels fall. By Day 3, the peak CRP of 220 mg/L reflects this production lag. Between Days 3 and 5, antibiotics have sufficiently reduced the bacterial burden that cytokine production begins to decline, and CRP falls to 180 mg/L. The steep decline to 40 mg/L by Day 7 is consistent with CRP's 19-hour half-life once hepatic production substantially ceases, indicating effective antibiotic therapy. If CRP had continued to rise or plateaued at Day 5–7, this would suggest treatment failure or a complication such as abscess formation.

Question 5: CRITICAL THINKING

Some pathogens, such as Mycobacterium tuberculosis and certain viruses, appear to benefit from the host's acute-phase response — for instance, by exploiting iron redistribution or macrophage activation for their own intracellular survival. Construct an argument for why the acute-phase response, despite being evolutionarily conserved, may represent an immunological 'trade-off' rather than a purely beneficial adaptation. In your answer, consider both the population-level and individual-level perspectives.

Show answer

The acute-phase response is best understood as a probabilistic strategy optimized at the population level rather than perfected for every individual encounter. At the population level, the response is strongly beneficial: fever enhances immune cell function and inhibits the growth of many common extracellular pathogens, CRP accelerates pathogen clearance through opsonization, and iron sequestration starves the majority of bacterial species. Natural selection has preserved this program because it improves survival on average across the diversity of infections a population encounters. However, at the individual level, certain pathogens have evolved counter-strategies: M. tuberculosis thrives inside activated macrophages, using the very inflammatory milieu the host creates; some intracellular bacteria can access sequestered iron stores within macrophage phagolysosomes; and fever-induced metabolic costs can be lethal in malnourished individuals or those with pre-existing organ compromise. This is a classic evolutionary trade-off: a defense mechanism that confers net fitness benefits across common infections may be co-opted or harmful in specific pathogen encounters. Additionally, the acute-phase response is inherently nonspecific — it cannot discriminate between pathogens that will be harmed by it and those that exploit it. The evolution of adaptive immunity, with its antigen-specific targeting, can be seen as nature's solution to the limitations of this broad-spectrum, innate strategy.

SUMMARY

Lesson Summary

Summary

The fever and acute-phase response represent the body's earliest systemic defense against infection and tissue injury. The process begins when sentinel immune cells — primarily macrophages — detect PAMPs via pattern-recognition receptors such as TLRs, activating NF-κB and triggering the release of endogenous pyrogens (IL-1β, TNF-α, IL-6). These cytokines reach the hypothalamus (OVLT), where they induce COX-2–dependent PGE₂ synthesis. PGE₂ binds EP3 receptors on thermoregulatory neurons, raising the set-point and producing fever through vasoconstriction, shivering, and increased metabolic rate. NSAIDs block COX-2 to reduce fever, but are ineffective against hyperthermia, which involves unregulated heat gain without set-point elevation.

In parallel, IL-6 drives the hepatic acute-phase protein program via the JAK-STAT3 pathway, massively upregulating positive APPs such as CRP (opsonization, complement), hepcidin (iron sequestration), and fibrinogen (coagulation), while reducing negative APPs like albumin and transferrin. The bone marrow contributes leukocytosis, and CNS cytokine action induces sickness behavior. This coordinated, multi-organ program is evolutionarily conserved and generally host-protective, though it carries metabolic costs and can become pathological in sepsis. Clinically, CRP (half-life ≈ 19 hours) serves as a dynamic biomarker for tracking infection resolution, and the acute-phase framework provides the conceptual foundation for advanced topics including inflammasome biology, complement cascades, and Th17 differentiation.